Baker Bros. Advisors »

Kiniksa Pharmaceuticals Intl P Ord Shs Cl A shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals Intl P Ord Shs Cl A (KNSA) shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals Intl P Ord Shs Cl A held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $70M 2.8M 24.99
2024-06-30 $53M 2.8M 18.67

More positions owned by Baker Bros. Advisors

BeiGene Sponsored Adr (BGNE)
Incyte Corporation (INCY)
ACADIA Pharmaceuticals (ACAD)
Summit Therapeutics (SMMT)
Madrigal Pharmaceuticals (MDGL)
Revolution Medicines (RVMD)
Rhythm Pharmaceuticals (RYTM)
Insmed Incorporated Com Par $.01 (INSM)
Kymera Therapeutics (KYMR)
Bicycle Therapeutics Sponsored Ads (BCYC)
Edgewise Therapeutics (EWTX)
Replimune Group (REPL)
Alkermes SHS (ALKS)
Denali Therapeutics (DNLI)
Insmed Incorporated Note 0.75% 6/1/2028 (Principal)

View all positions for Baker Bros. Advisors

Top funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

BlackRock
BlackRock
Fairmount Funds Management
Braidwell
Baker Bros. Advisors
Rubric Capital Management
Morgan Stanley
Hillhouse Capital Advisors
State Street Corporation
Pictet Asset Management Holding SA
Nuveen Asset Management
Dimensional Fund Advisors
Driehaus Capital Management
Rice Hall James & Associates
Parkman Healthcare Partners

View all funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A